CRISTA WELLS: Open Payments
NPI 1023531571 · BLUE HILL, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,386 in 22 payments from 7 companies in 2025. Trend: 2023 $16 · 2024 $216 · 2025 $8,386
Consulting: $8,053Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Phadia US Inc. | 9 | $7,013 |
| Novartis Pharmaceuticals Corporation | 1 | $1,040 |
| Amgen Inc. | 6 | $130 |
| Janssen Biotech, Inc. | 1 | $87 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
Products named: ImmunoCAP, TREMFYA, BENLYSTA, ENBREL, Otezla, UPLIZNA, ORENCIA, UPTRAVI.
Industry payments across ME — which companies pay providers there.
